Aardvark Therapeutics Faces Class Action Over IPO Disclosures
DJS Law Group sues AARD over alleged misleading statements about its ARD-101 drug during its IPO window. Shareholders have until October 2026 to act.
If you bought shares of Aardvark Therapeutics (NASDAQ: AARD) between February 13, 2025, and May 14, 2026, you might want to pay attention. The DJS Law Group has filed a class action lawsuit against the biotech company, claiming it made false and misleading statements to investors about the commercial potential of its lead drug candidate, ARD-101, during that IPO period.
In plain terms, a class action like this means a group of investors bands together to sue a company they believe deceived them. Here, the allegation is that Aardvark painted an overly rosy picture of ARD-101's prospects while it was going public — the kind of optimism that can artificially inflate a stock price and leave ordinary investors holding the bag when reality sets in.
Read more MicroCloud Hologram Buys 140,268 MSTR Shares via Structured Notes →
If you lost money on AARD shares during that timeframe, the law firm is inviting you to reach out and explore your options, including the possibility of being named a lead plaintiff in the case. That role carries a bit more responsibility — and potentially more say in how the lawsuit unfolds — but it's not required to participate in any eventual settlement.
The deadline to contact DJS Law Group about a lead plaintiff appointment is October 13, 2026, so affected shareholders aren't under immediate pressure, but waiting too long could limit your options. Securities class actions can drag on for years, but missing key deadlines early in the process is a common way investors accidentally sideline themselves.
It's worth noting that a lawsuit is not a verdict — Aardvark Therapeutics has not been found guilty of anything, and the company has the opportunity to defend itself. Still, for retail investors who rode AARD down during its IPO window, this filing signals there may be a legal path to recovering some of those losses. Continue reading at WBOC TV.
